CAMP4 Therapeutics (CAMP) Cash Flow Statement

Click line-items for a historical chart and %

Net income (loss)	-2.14M
Depreciation and amortization
Stock-based compensation expense	3.61M
Non-cash interest expense
Write-off of currency translation account of foreign subsidiary
Deferred tax assets, net	-1.09M
Other
Accounts receivable	1.81M
Inventories	2.04M
Costs and estimated earnings in excess of billings on uncompleted contracts
Prepaid expenses and other assets	2.82M
Accounts payable	1.93M
Accrued liabilities	-6.86M
Deferred revenue	760K
NET CASH PROVIDED BY OPERATING ACTIVITIES	19.32M
Capital expenditures
Collections on note receivable
NET CASH USED IN INVESTING ACTIVITIES	-54.86M
Net debt proceeds (repayments) on bank line of credit
Proceeds from bank term loan
Repayment of subordinated notes payable
Payment of debt issue costs	0
Taxes paid related to net share settlement of vested equity awards	-1.42M
Proceeds from exercise of stock options	780K
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	-9.09M
Net change in cash and cash equivalents	-44.68M
Cash and cash equivalents at beginning of period	139.39M
Cash and cash equivalents at end of period	94.71M

Entities mentioned with CAMP

View All Entities